Large sets of quality data can provide insights to support drug development decisions.
Drug discovery leaves too much to chance. This model of research and development has outlived its usefulness. New drugs are complex products that need to be developed using processes similar to the ones used in other industries.
Drug development programs need more and better data. They need insights to guide rapid iterations leading to better products and stronger patents.
See how GenoFAB is transforming the R&D process to produce more information-rich data.